AFIB logo

Acutus Medical (AFIB)

Profile

Full Name

Acutus Medical, Inc.

Ticker Symbol

AFIB

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 6, 2020

Indexes

Not included

Website

http://www.acutusmedical.com

Employees

85

Key Details

Price

$0.04(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$20.16M(+181.37% YoY)

Annual EPS

-$0.32(+88.61% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.04
AFIB price is $0.04

30-Day Relative Volume

0.33
AFIB 30-day relative volume is 0.33

Price Performance

Price Most recent change

0%
AFIB {parameterFullLabel} has remained unchanged on Apr 14, 2025

Price YTD change

-34.55%
AFIB price is down -34.55% since January 1st

Price 1-year change

-78.82%
AFIB price is down -78.82% year-on-year

Price 3-year change

-95.93%
AFIB price is down -95.93% over the past 3 years

Price Range

Price All-time high

$38.99
AFIB price is currently -99.91% below its historical high of $38.99

Price 3-year low

$0.03
AFIB price is currently +44.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.08M
AFIB market capitalization is $1.08 million

Market cap 3-year change

-95.7%
AFIB market capitalization is down -95.7% over the past 3 years

Market cap All-time high

$1.03B
AFIB market capitalization is currently -99.90% below its historical high of $1.03 billion

Market cap sector rank

4.19%
AFIB market capitalization is higher than 4.19% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.66%
AFIB shares outstanding is up +0.66% year-on-year

Shares Outstanding 3-Year Change

+5.78%
AFIB shares outstanding is up +5.78% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.38
AFIB beta is 1.38

200-day SMA

$0.06
AFIB price is currently -42.40% below its 200-day simple moving average

50-day SMA

$0.05
AFIB price is currently -25.47% below its 50-day simple moving average

RSI

38.71
AFIB 14-day relative strength index is 38.71

Volume

0.33
AFIB 30-day relative volume is 0.33

ATR

$0.01
AFIB average true range is $0.01

10-day Historical Volatility

161.19%
AFIB 10-day historical volatility is 161.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.16M
AFIB annual revenue is $20.16 million

Revenue Analysts estimate

-
AFIB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+181.37%
AFIB annual revenue is up +181.37% year-on-year

Revenue Sector rank

34.6%
AFIB annual revenue is higher than 34.6% of companies in Healthcare sector

EPS

EPS

-$0.32
AFIB annual earnings per share is -$0.32

EPS Analysts estimate

-
AFIB annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+88.61%
AFIB annual earnings per share is up +88.61% year-on-year

EPS Sector rank

73.95%
AFIB annual earnings per share is higher than 73.95% of companies in Healthcare sector

Profit

Gross profit

$1.01M
AFIB annual gross profit is $1.01 million

Gross margin

5.03%
AFIB annual gross profit margin is 5.03%

Operating profit

-$9.42M
AFIB annual operating income is -$9.42 million

Operating margin

-46.75%
AFIB annual operating profit margin is -46.75%

Net income

-$9.55M
AFIB annual net profit is -$9.55 million

Net margin

-47.36%
AFIB annual net profit margin is -47.36%

Expenses

Total expenses

$29.58M
AFIB annual total expenses is $29.58 million

Operating expenses

$10.44M
AFIB annual total operating expenses is $10.44 million

Cost of goods sold

$19.14M
AFIB annual cost of goods sold is $19.14 million

Selling, general & administrative expenses

$10.44M
AFIB annual SGA is $10.44 million

Depreciation and amortization

$1.03M
AFIB annual depreciation & amortization is $1.03 million

Interest expense

$5.76M
AFIB annual interest expense is $5.76 million

Income tax

$0.00
AFIB annual income tax is $0.00

EBIT & EBITDA

EBIT

$1.22M
AFIB annual earnings before interest & taxes is $1.22 million

EBITDA

$2.25M
AFIB annual EBITDA is $2.25 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$28.65M
AFIB annual total assets is $28.65 million

Non current assets

$3.07M
AFIB annual long term assets is $3.07 million

Current assets

$25.58M
AFIB annual total current assets is $25.58 million

Cash and cash equivalents

$14.02M
AFIB annual cash & cash equivalents is $14.02 million

Accounts receivable

$7.88M
AFIB annual accounts receivable is $7.88 million

Inventory

$1.79M
AFIB annual inventory is $1.79 million

Liabilities

Total liabilities

$40.24M
AFIB annual total liabilities is $40.24 million

Long term liabilities

$27.80M
AFIB annual total long term liabilities is $27.80 million

Current liabilities

$12.44M
AFIB annual total current liabilities is $12.44 million

Accounts payable

$1.28M
AFIB annual accounts payable is $1.28 million

Debt

Total debt

$35.76M
AFIB annual total debt is $35.76 million

Total debt 1-year change

-7.06%
AFIB annual total debt is down -7.06% year-on-year

Long term debt

$27.80M
AFIB annual long term debt is $27.80 million

Short term debt

$7.96M
AFIB annual short term debt is $7.96 million

Equity & Capital

Shareholders equity

-$11.59M
AFIB annual stockholders equity is -$11.59 million

Book value

-$11.59M
AFIB annual book value is -$11.59 million

Retained earnings

-$609.52M
AFIB annual retained earnings is -$609.52 million

Working capital

$13.14M
AFIB annual working capital is $13.14 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$31.66M
AFIB annual cash flow from operations is -$31.66 million

Cash from operations 1-year change

+49.84%
AFIB annual cash flow from operations is up +49.84% year-on-year

Cash from investing

$22.15M
AFIB annual cash flow from investing activities is $22.15 million

Cash from investing 1-year change

-62.17%
AFIB annual cash flow from investing activities is down -62.17% year-on-year

Cash from financing

-$2.89M
AFIB annual cash flow from financing activities is -$2.89 million

Cash from financing 1-year change

-8.52%
AFIB annual cash flow from financing activities is down -8.52% year-on-year

CAPEX

CAPEX

$112.00K
AFIB annual capital expenditures is $112.00 thousand

CAPEX 1-year change

-48.86%
AFIB annual capital expenditures is down -48.86% year-on-year

Free Cash Flow

Free cash flow

-$31.77M
AFIB annual free cash flow is -$31.77 million

Free cash flow 1-year change

+49.84%
AFIB annual free cash flow is up +49.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

5.03%
AFIB annual gross profit margin is 5.03%

Operating margin

-46.75%
AFIB annual operating profit margin is -46.75%

Net margin

-47.36%
AFIB annual net profit margin is -47.36%

ROA & ROE

ROA

-23.11%
AFIB annual return on assets is -23.11%

ROE

82.36%
AFIB annual return on equity is 82.36%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AFIB price to earnings ratio value is unknown

PE ratio Sector rank

-
AFIB price to earnings ratio is unknown

PB Ratio

PB ratio

-0.09
AFIB price to book ratio is -0.09

PB ratio Sector rank

13.33%
AFIB price to book ratio is higher than 13.33% of companies in Healthcare sector

PS Ratio

PS ratio

0.05
AFIB price to sales ratio is 0.05

PS ratio Sector rank

3.72%
AFIB price to sales ratio is higher than 3.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$22.82M
AFIB enterprise value is $22.82 million

Enterprise value Sector rank

33.47%
AFIB enterprise value is higher than 33.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.19
AFIB EV/EBITDA is 10.19

EV/EBITDA Sector rank

82.7%
AFIB EV/EBITDA is higher than 82.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.06
AFIB annual current ratio is 2.06

Quick ratio

1.91
AFIB annual quick ratio is 1.91

Leverage

Debt to equity

-2.81
AFIB annual debt to equity ratio is -2.81

Interest coverage ratio

0.21
AFIB annual interest coverage ratio is 0.21

Risk & Stability

Piotroski F-Score

3
AFIB piotroski f-score is 3

Altman Z-Score

-28.38
AFIB altman z-score is -28.38

Analyst ratings

Recent major analysts updates

Aug 16, 22 Goldman Sachs
Neutral
Jun 24, 22 BTIG
Buy
Apr 27, 22 BTIG
Buy
Apr 14, 22 Goldman Sachs
Neutral
Jan 20, 22 BTIG
Neutral
Jan 14, 22 Canaccord Genuity
Hold
Nov 12, 21 JP Morgan
Underweight
Nov 12, 21 Canaccord Genuity
Buy
Oct 22, 21 Goldman Sachs
Neutral
Jul 15, 21 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

DYNT logo
Dynatronics (DYNT)
BDRX logo
Biodexa Pharmaceuticals (BDRX)
WINT logo
Windtree Therapeutics (WINT)
APDN logo
Applied DNA Sciences (APDN)
BIOC logo
Biocept (BIOC)
BIOR logo
Biora Therapeutics (BIOR)
SLRX logo
Salarius Pharmaceuticals (SLRX)
TRVN logo
Trevena (TRVN)
ISPC logo
iSpecimen (ISPC)
  • What is the ticker symbol for Acutus Medical?
  • Does Acutus Medical pay dividends?
  • What sector is Acutus Medical in?
  • What industry is Acutus Medical in?
  • What country is Acutus Medical based in?
  • When did Acutus Medical go public?
  • Is Acutus Medical in the S&P 500?
  • Is Acutus Medical in the NASDAQ 100?
  • Is Acutus Medical in the Dow Jones?
  • When was Acutus Medical's last earnings report?
  • When does Acutus Medical report earnings?
  • Should I buy Acutus Medical stock now?

What is the ticker symbol for Acutus Medical?

The ticker symbol for Acutus Medical is NASDAQ:AFIB

Does Acutus Medical pay dividends?

No, Acutus Medical does not pay dividends

What sector is Acutus Medical in?

Acutus Medical is in the Healthcare sector

What industry is Acutus Medical in?

Acutus Medical is in the Medical Devices industry

What country is Acutus Medical based in?

Acutus Medical is headquartered in United States

When did Acutus Medical go public?

Acutus Medical's initial public offering (IPO) was on August 6, 2020

Is Acutus Medical in the S&P 500?

No, Acutus Medical is not included in the S&P 500 index

Is Acutus Medical in the NASDAQ 100?

No, Acutus Medical is not included in the NASDAQ 100 index

Is Acutus Medical in the Dow Jones?

No, Acutus Medical is not included in the Dow Jones index

When was Acutus Medical's last earnings report?

Acutus Medical's most recent earnings report was on Mar 24, 2025

When does Acutus Medical report earnings?

The next expected earnings date for Acutus Medical is May 9, 2025

Should I buy Acutus Medical stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page